ARCHIVES

Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990

This article is from The Cancer Letter archive.

Vol. 15 No. 04 | January 27, 1989

Download PDF Visit The Full Archive

Related Articles

In Brief: Hammond Honored By ACS; SEER Celebrates 20th Anniversary With Symposium Dec. 8

December 3, 1993

HRSA: Discounts Owed on Some Orphan Drug Uses

October 24, 2014

In Brief: BRI Gets New FCRF Basic Research Contract; Senate Subcommittee Less Generous Than House

October 2, 1987

NCCS Networker Volume 11 Issue 1, Spring 1997 Special Report: The Cancer Bill

April 13, 1997

Money Earmarked for WVU Center Could Be Returned To Treasury; BYRD Get Assurances From DeVita

May 31, 1985

CT Scanning Use, Costs, Controls Debated By NCAB

October 7, 1977